1. Home
  2. PRCT vs PK Comparison

PRCT vs PK Comparison

Compare PRCT & PK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PRCT
  • PK
  • Stock Information
  • Founded
  • PRCT 2009
  • PK 1946
  • Country
  • PRCT United States
  • PK United States
  • Employees
  • PRCT N/A
  • PK N/A
  • Industry
  • PRCT Medical Specialities
  • PK Real Estate Investment Trusts
  • Sector
  • PRCT Health Care
  • PK Real Estate
  • Exchange
  • PRCT Nasdaq
  • PK Nasdaq
  • Market Cap
  • PRCT 2.9B
  • PK 2.5B
  • IPO Year
  • PRCT 2021
  • PK N/A
  • Fundamental
  • Price
  • PRCT $53.03
  • PK $9.83
  • Analyst Decision
  • PRCT Strong Buy
  • PK Buy
  • Analyst Count
  • PRCT 7
  • PK 10
  • Target Price
  • PRCT $91.43
  • PK $16.39
  • AVG Volume (30 Days)
  • PRCT 1.0M
  • PK 5.7M
  • Earning Date
  • PRCT 04-24-2025
  • PK 05-05-2025
  • Dividend Yield
  • PRCT N/A
  • PK 14.66%
  • EPS Growth
  • PRCT N/A
  • PK 129.54
  • EPS
  • PRCT N/A
  • PK 1.01
  • Revenue
  • PRCT $224,498,000.00
  • PK $2,611,000,000.00
  • Revenue This Year
  • PRCT $46.28
  • PK $3.10
  • Revenue Next Year
  • PRCT $32.67
  • PK $3.38
  • P/E Ratio
  • PRCT N/A
  • PK $9.73
  • Revenue Growth
  • PRCT 64.84
  • PK N/A
  • 52 Week Low
  • PRCT $47.04
  • PK $8.27
  • 52 Week High
  • PRCT $103.81
  • PK $16.95
  • Technical
  • Relative Strength Index (RSI)
  • PRCT 42.69
  • PK 41.81
  • Support Level
  • PRCT $51.27
  • PK $9.47
  • Resistance Level
  • PRCT $54.75
  • PK $9.89
  • Average True Range (ATR)
  • PRCT 3.64
  • PK 0.63
  • MACD
  • PRCT 0.19
  • PK 0.05
  • Stochastic Oscillator
  • PRCT 49.48
  • PK 57.56

About PRCT PROCEPT BioRobotics Corporation

PROCEPT BioRobotics Corp is a surgical robotics company focused on advancing patient care by developing transformative solutions in urology. It develops, manufactures, and sells the AquaBeam Robotic System and HYDROS Robotic System, which are image-guided, surgical robotic systems for use in minimally invasive urologic surgery, with an initial focus on treating benign prostatic hyperplasia, or BPH. Geographically, the company generates a majority of its revenue from the United States and also has a presence in markets outside the U.S.

About PK Park Hotels & Resorts Inc.

Park Hotels & Resorts owns upper-upscale and luxury hotels with 22,711 rooms across 37 hotels in the United States. Park also has interests through joint ventures in another 2,271 rooms in three US hotels. Park was spun out of narrow-moat Hilton Worldwide Holdings at the start of 2017, so most of the company's hotels are still under Hilton brands. The company has sold all its international hotels and many of its lower-quality US hotels to focus on high-quality assets in domestic gateway markets.

Share on Social Networks: